435 related articles for article (PubMed ID: 33137890)
1. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
Shematorova EK; Shpakovski GV
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
[TBL] [Abstract][Full Text] [Related]
3. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
[TBL] [Abstract][Full Text] [Related]
4. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
[TBL] [Abstract][Full Text] [Related]
5. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16.
Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I
Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979
[TBL] [Abstract][Full Text] [Related]
6. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
[TBL] [Abstract][Full Text] [Related]
8. A novel in-frame mutation in
Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
[No Abstract] [Full Text] [Related]
9. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
[TBL] [Abstract][Full Text] [Related]
10. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
[TBL] [Abstract][Full Text] [Related]
11. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
[TBL] [Abstract][Full Text] [Related]
12. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
13. Caenorhabditis elegans homologues of the CLN3 gene, mutated in juvenile neuronal ceroid lipofuscinosis.
De Voer G; Jansen G; van Ommen GJ; Peters DJ; Taschner PE
Eur J Paediatr Neurol; 2001; 5 Suppl A():115-20. PubMed ID: 11588981
[TBL] [Abstract][Full Text] [Related]
14. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME
Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761
[TBL] [Abstract][Full Text] [Related]
15. Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).
Ouseph MM; Kleinman ME; Wang QJ
Ann N Y Acad Sci; 2016 May; 1371(1):55-67. PubMed ID: 26748992
[TBL] [Abstract][Full Text] [Related]
16. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.
Rakheja D; Narayan SB; Bennett MJ
Curr Mol Med; 2007 Sep; 7(6):603-8. PubMed ID: 17896996
[TBL] [Abstract][Full Text] [Related]
17. Moving towards therapies for juvenile Batten disease?
Cooper JD
Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
[TBL] [Abstract][Full Text] [Related]
18. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties.
Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT
Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079
[TBL] [Abstract][Full Text] [Related]
19. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
